secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2024-04-25T23:59:59+00:00
Accession:  0001404644-24-000041
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurogene amends CSO Stuart Cobb's consulting agreement; sets $440K annual fee, success bonus up to 40%
--------------------------------------------------------------------------------

- Dr. Stuart Cobb to continue as CSO under amended consulting agreement with Neurogene.
- Minimum annual consulting fee of $440,000 paid monthly; eligible for annual success fee of up to 40%.
- Termination without cause or for good reason: lump sum of 1.0x annual fee plus pro-rata bonus (non-CIC) or (CIC) includes equity acceleration.
- Agreement effective April 19, 2024; replaces prior consulting agreement from December 2018.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000140464424000041/0001404644-24-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000140464424000041/ngne-20240419.htm
  HTML page:      https://secwatch.observer/filing/0001404644-24-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer